These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38370965)
1. Acceptance and commitment therapy as an add-on treatment for the management of patients with obsessive-compulsive disorder. Akhouri D; Hamza ; Kumar S; Reyazuddin M Ind Psychiatry J; 2023 Nov; 32(Suppl 1):S179-S185. PubMed ID: 38370965 [TBL] [Abstract][Full Text] [Related]
2. Relationship Between Cognitive Fusion, Experiential Avoidance, and Obsessive-Compulsive Symptoms in Patients With Obsessive-Compulsive Disorder. Xiong A; Lai X; Wu S; Yuan X; Tang J; Chen J; Liu Y; Hu M Front Psychol; 2021; 12():655154. PubMed ID: 33912117 [No Abstract] [Full Text] [Related]
3. Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive-Compulsive Disorder. Zou J; Wu S; Yuan X; Hu Z; Tang J; Hu M Front Psychiatry; 2021; 12():720518. PubMed ID: 35095583 [No Abstract] [Full Text] [Related]
4. The effectiveness of acceptance and commitment therapy in treating a case of obsessive compulsive disorder. Vakili Y; Gharraee B Iran J Psychiatry; 2014 Apr; 9(2):115-7. PubMed ID: 25632289 [TBL] [Abstract][Full Text] [Related]
5. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder. Vakili Y; Gharaee B; Habibi M Iran J Psychiatry Behav Sci; 2015 Jun; 9(2):e845. PubMed ID: 26288647 [TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. Twohig MP; Hayes SC; Plumb JC; Pruitt LD; Collins AB; Hazlett-Stevens H; Woidneck MR J Consult Clin Psychol; 2010 Oct; 78(5):705-16. PubMed ID: 20873905 [TBL] [Abstract][Full Text] [Related]
7. Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults. Castro-Rodrigues P; Camacho M; Almeida S; Marinho M; Soares C; Barahona-Corrêa JB; Oliveira-Maia AJ Front Psychiatry; 2018; 9():431. PubMed ID: 30254588 [No Abstract] [Full Text] [Related]
8. The Suitability of Different Subtypes and Dimensions of Obsessive-Compulsive Disorder for Treatment with Anterior Capsulotomy: A Long-Term Follow-Up Study. Gong F; Li B; Zhang S; Wang Y; Gao Y; Xu Y; Wang X; Xiong B; Li D; Wen R; Qin Z; Wang W Stereotact Funct Neurosurg; 2019; 97(5-6):319-336. PubMed ID: 31786574 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with the duration of untreated illness among patients with obsessive compulsive disorder. Poyraz CA; Turan Ş; Sağlam NG; Batun GÇ; Yassa A; Duran A Compr Psychiatry; 2015 Apr; 58():88-93. PubMed ID: 25596625 [TBL] [Abstract][Full Text] [Related]
11. A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders. Say Öcal D; Özdel K; Şafak Y; Kekilli Karnaz Y; Kısa C PLoS One; 2019; 14(7):e0218955. PubMed ID: 31276509 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Rajyoga meditation as an adjunct to first-line treatment in patients with obsessive compulsive disorder. Mehta K; Mehta S; Chalana H; Singh H; Thaman RG Indian J Psychiatry; 2020; 62(6):684-689. PubMed ID: 33896974 [TBL] [Abstract][Full Text] [Related]
13. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders. Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661 [TBL] [Abstract][Full Text] [Related]
14. Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples. Hiranyatheb T; Saipanish R; Lotrakul M Neuropsychiatr Dis Treat; 2014; 10():471-7. PubMed ID: 24648741 [TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition. Hiranyatheb T; Saipanish R; Lotrakul M; Prasertchai R; Ketkaew W; Jullagate S; Udomsubpayakul U; Kusalaruk P Neuropsychiatr Dis Treat; 2015; 11():2817-24. PubMed ID: 26604766 [TBL] [Abstract][Full Text] [Related]
16. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder. Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323 [TBL] [Abstract][Full Text] [Related]
17. Executive Functions of Obsessive Compulsive Disorder and Panic Disorder Patients in Comparison to Healty Controls. Kurt E; Yildirim E; Topçuoğlu V Noro Psikiyatr Ars; 2017 Dec; 54(4):312-317. PubMed ID: 29321703 [TBL] [Abstract][Full Text] [Related]
18. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test]. Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567 [TBL] [Abstract][Full Text] [Related]
19. A study of cognitive function in treatment-refractory obsessive-compulsive disorder treated with capsulotomy. Gong F; Li P; Li B; Zhang S; Zhang X; Yang S; Liu H; Wang W J Neurosurg; 2018 Feb; 128(2):583-595. PubMed ID: 28338440 [TBL] [Abstract][Full Text] [Related]
20. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder. Besiroglu L; Çetinkaya N; Selvi Y; Atli A Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]